
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Chamomilla is a homeopathic preparation of German chamomile containing apigenin and bisabolol as key bioactive compounds. It works by modulating GABA neurotransmission and reducing inflammatory cytokines to provide calming and digestive benefits.

Reported Benefits (Provisional)
Origin & History

Chamomilla is derived from the chamomile plant, a member of the daisy family. It is prepared through a process of serial dilution and succussion in homeopathy.
Research Narrative (Provisional)
There is limited scientific evidence for the efficacy of Chamomilla in homeopathy. Some small studies suggest potential benefits for teething and colic, but more rigorous research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Chamomilla (homeopathic preparation, typically derived from Matricaria chamomilla / German Chamomile) is administered in highly diluted potencies (e.g., 6C, 12C, 30C, 200C) rather than as a crude herb, so conventional macronutrient and micronutrient values are negligible to essentially zero at potencies above 12C (beyond Avogadro's limit). However, the source material (mother tincture) contains the following bioactive compounds of relevance: Bioactive Compounds in Mother Tincture / Low-Potency Preparations: - Chamazulene: ~1–15% of essential oil fraction; anti-inflammatory sesquiterpene formed during steam distillation from matricin. - α-Bisabolol (levomenol): ~10–65% of essential oil; anti-inflammatory, antimicrobial, and spasmolytic activity. - Bisabolol oxides A & B: ~10–25% of essential oil; contribute to anti-inflammatory effects. - Apigenin: major flavonoid, approximately 3–5 mg per gram of dried flower equivalent; binds benzodiazepine receptors, modulating GABAergic neurotransmission (anxiolytic/sedative). - Apigenin-7-O-glucoside: water-soluble glycoside form; bioavailability improved by intestinal hydrolysis. - Luteolin: ~0.2–1.0 mg/g dried flower equivalent; antioxidant and anti-inflammatory flavonoid. - Quercetin: trace to ~0.5 mg/g; antioxidant flavonoid. - Matricin: ~0.1–0.3% of dried flower; pro-chamazulene sesquiterpene lactone with anti-inflammatory action. - Coumarins (herniarin, umbelliferone): trace amounts (~0.1%); mild spasmolytic properties. - Polysaccharides (mucilages): present in crude extract; contribute to GI mucosal soothing. - Minerals (in crude plant): Calcium (~7–10 mg/g), Potassium (~20–35 mg/g), Magnesium (~2–4 mg/g), Zinc (~30–50 µg/g), Iron (~100–200 µg/g) — these are effectively absent in homeopathic dilutions above ~3X/1C. Macronutrients: Not applicable in homeopathic dosing; caloric value is essentially zero. Fiber/Protein: Not applicable in diluted homeopathic preparations. Bioavailability Notes: In homeopathic potencies of 6C and above, measurable molecular concentrations of the original compounds are extremely low or absent per Avogadro's number considerations. Low potencies (mother tincture, 1X–6X) retain quantifiable amounts of apigenin, bisabolol, and other actives. Apigenin has moderate oral bioavailability (~20–30%) with significant first-pass metabolism; bisabolol is lipophilic with good transmucosal absorption. Homeopathic theory attributes therapeutic action to the potentization (serial dilution and succussion) process rather than to conventional dose-dependent pharmacology.
Reported Mechanism (Provisional)
Chamomilla's primary compound apigenin binds to benzodiazepine receptors in the brain, enhancing GABA neurotransmission to produce anxiolytic effects. The anti-inflammatory compound bisabolol inhibits cyclooxygenase and lipoxygenase enzymes, reducing inflammatory mediators like TNF-alpha and IL-1β in gastrointestinal tissues. This dual mechanism provides both neurological calming and digestive tract soothing effects.
Clinical Narrative (Provisional)
Limited clinical research exists specifically for homeopathic chamomilla preparations. Most evidence comes from studies on German chamomile extract, including a randomized controlled trial of 57 participants showing significant anxiety reduction after 8 weeks of treatment. Pediatric studies with sample sizes of 68-93 infants demonstrated reduced colic symptoms within 7 days. However, homeopathic dilutions lack robust clinical validation, and evidence quality remains moderate due to small sample sizes and methodological limitations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







